DistantNews
Support us
๐Ÿ‡น๐Ÿ‡ผ Taiwan /Culture & Society

Taiwanese Singer Chou Huei Reveals Vocal Cord Atrophy, Shares Hopeful Treatment Update

From Liberty Times · () Chinese

Translated from Chinese, summarized and contextualized by DistantNews.

At a glance

News Sources not specified Outcome reported
  • Taiwanese singer Chou Huei revealed she has been suffering from vocal cord atrophy.
  • She confessed to fans during a concert that it might be her last performance.
  • After undergoing treatment, she shared positive news about her recovery progress.

Taiwanese singer Chou Huei (ๅ‘จ่•™) has revealed she has been battling vocal cord atrophy, a condition that caused her significant distress. The acclaimed vocalist shared this personal struggle with fans during her recent concert at the Taipei International Convention Center.

During the performance in April, Chou Huei fell seriously ill with a severe cold, which led to the discovery of her vocal cord condition. Towards the end of the concert, she emotionally confessed to the audience, "I don't know if this will be my last time singing for everyone," bringing many to tears.

Following the concert, Chou Huei committed to an intensive treatment plan. She recently shared an update on social media, bringing relief to her fans. She announced that the first phase of her treatment has concluded successfully. "My vocal cords' first stage of treatment is complete. The doctor said the repair is going very well," she shared, adding that she will have follow-up appointments quarterly for monitoring and potential further treatment.

Fans have flooded her social media with well wishes, expressing their hope for her swift and full recovery. Chou Huei had previously promised her fans she would return after resting and recuperating, and this update signals a positive step towards fulfilling that promise.

DistantNews Editorial

Originally published by Liberty Times in Chinese. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.